期刊文献+

HCVNS5A-B片段的表达及在酶活性研究中的应用 被引量:5

Preparation of recombinant IL-1 fusion protein as the substrate for HCV NS3 serine protease
下载PDF
导出
摘要 目的利用原核表达载体pBVIL1,表达丙型肝炎病毒非结构蛋白3(NS3)丝氨酸蛋白酶催化底物NS5A-B小分子,为进一步研究蛋白酶活性提供方法学。方法将PCR合成的NS5A-B(2412-2427aa)基因直接插入高效原核表达载体pBVIL1,融合表达NS5A-B片段,包涵体形式的表达产物用8mol/L脲溶解后,采用离子交换和凝胶过滤两步纯化。利用SDS-PAGE、Western blot和ELISA方法,于37℃酶催化条件下,分析NS5A-B底物的降解活性。结果(1)构建了pBVIL1/NS5A-B重组质粒,鉴定证明NS5A-B基因片段正确地插入表达载体上。融合蛋白在转化质粒的HB101菌中得到高效表达。分离纯化重组蛋白后浓度可达0.73g/L。(2)在NS3蛋白酶作用不同时间后,用SDS-PAGE和Western blot证实,底物带可被明显降解,ELISA分析也证明,NS5A-B具有酶底物活性。结论含有酶切位点的NS5A-B融合蛋白可被NS3丝氨酸蛋白酶有效地降解,可用作为NS3蛋白酶的底物,可替代全长NS5A-B和化学合成肽用于酶活性和酶阻断剂的研究。 AIM: To prepare recombinant IL-I fusion protein as the substrate for the HCV NS3 serine protease. METHODS: NSSA-B gene fragment (2 412 -2 427aa) synthesized by PCR was subcloned into prokaryotic expression vector pBVIL1 to fuse with IL-1 gene and the recombinant vector pBVIL1/NSSA-B was transformed into E. coil strain HB101. The fused protein was induced to express at 42℃ and purified by two-step column chromatography. The proteolysis of the purified IL-1 fusion protein catalyzed by NS3 serine protease was analyzed with SDS-PAGE, Western blot and ELISA. RESULTS: NSSA-B fragment gene was correctly subcloned into pBVIL1 vector and the fusion protein was expressed as inclusion body in transformed HB101 cells. The recombinant fusion protein can be cleaved into smaller fragments by NS3 protease. CONCLUSION: The recombinant fusion protein can be cleaved by NS3 serine protease successfully and specifically, suggesting that it can be used as a surrogate substrate of NS3 serine protease in searching for inhibitors of this protease.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2006年第1期43-46,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家"十五"重大科技攻关计划资助项目(No.2001BA705B060)
关键词 丙型肝炎病毒 非结构蛋白5A—B 原核表达 pBVILI HCV NSSA-B prokaryotic expression pBVIL1
  • 相关文献

参考文献2

二级参考文献14

  • 1李伍举,吴加金.pBV220载体中外源基因表达水平定量分析[J].病毒学报,1997,13(2):126-133. 被引量:29
  • 2Llinas-Brunet M,Bailey M,Fazal G,Ghiro E,Gorys V,Goulet S,Halmos T,Maurice R,Poirier M,Poupart MA,Rancourt J,Thibeault D,Wernic D,Lamarre D.Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease:towards smaller inhibitors[].Bioorg Med Chem Left.2000
  • 3Grakoui A,McCourt DW,Wychowski C,Feinstone SM,Rice CM.Characterization of the hepatitis C virus-encoded serine proteinase:determination of proteinase-dependent polyprotein cleavage sites[].JViro.1993
  • 4Landro JA,Raybuck SA,Luong YP,O‘Malley ET,Harbeson SL,Morgenstern KA,Rao G,Livingston DJ.Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus:elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping[].Biochemistry.1997
  • 5Chen Z,Xu J,Song HB,Zhou YS,Wang HT.Cloning and sequence analysis of hepatitis C virus NS3 serine protease[].Chinese Journal of Hepatology.1998
  • 6Taremi SS,Beyer B,Maher M,Yao N,Prosise W,Weber PC,Malcolm BA.Construction,expression,and characterization of a novel fully activated recombinant single-chain hepatitis C virus protease[].Protein Science.1998
  • 7Ingallinella P,Fattori D,Altamura S,Steinkuhler C,Koch U,Cicero D,Bazzo R,Cortese R,Bianchl E,Pessi A.Prime site binding inhibitors of a serine protease:NS3/4A of hepatitis C virus[].Biochemistry.2002
  • 8Shoji I,Suzuki T,Chieda S,Sato M,Harada T,Chiba T,Matsuura Y,Miyamura T.Proteolytic activity of NS3 serine proteinase of hepatitis C virus efficiently expressed in Escherichia coil[].Hepatology.1995
  • 9Cerretani M,Di Renzo L,Serafini S,Vitelli A,Gennari N,Bianchi E,Pessi A,Urbani A,Colloca S,De Francesco R,Steinkuhler C,Altamura S.A high-throughput radiometric assay for hepatitis C virus NS3 protease[].Analytical Biochemistry.1999
  • 10Choo QL,Kuo G,Weiner AJ,Overby LR,Bradley DW,Houghton M.Isolation of a cDNA clone derived from a bloodborne non-A, non-B viral hepatitis genome[].Science.1989

共引文献37

同被引文献31

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部